Moderate-to-Vigorous Exercise Can Delay Mortality in Inoperable Lung Cancer

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Jan 8, 2024.

By Lori Solomon HealthDay Reporter

MONDAY, Jan. 8, 2024 -- Higher device-measured moderate- to vigorous-intensity physical activity (MVPA) is associated with reduced 12-month mortality in people newly diagnosed with inoperable lung cancer, according to a study published online Nov. 27 in the Journal of Clinical Medicine.

Vinicius Cavalheri, Ph.D., from Curtin University in Perth, Australia, and colleagues examined device-measured PA and sedentary behavior at the time of diagnosis in people with inoperable lung cancer and investigated PA associations with 12-month mortality. The analysis included 89 participants.

The researchers found that overall, 12-month mortality was 30 percent. However, participants who spent >4.6 minutes/day in MVPA had a lower relative risk of 12-month mortality compared with those who spent ≤4.6 minutes/day in MVPA (hazard ratio, 0.40; 18 versus nine deaths). No other measures of PA/sedentary behavior were associated with 12-month mortality.

"These new findings further indicate that health care providers should investigate a person’s levels of physical activity in early management of inoperable lung cancer," Cavalheri said in a statement. "We also need to evaluate what can be done to encourage people with inoperable lung cancer to exercise more, as 24 percent of the study’s participants engaged in less than one minute per day of moderate-to-vigorous physical activity."

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-01-09 02:15

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords